BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martins J, Elvas F, Brudzewsky D, Martins T, Kolomiets B, Tralhão P, Gøtzsche CR, Cavadas C, Castelo-Branco M, Woldbye DP, Picaud S, Santiago AR, Ambrósio AF. Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro. ASN Neuro 2015;7:1759091415598292. [PMID: 26311075 DOI: 10.1177/1759091415598292] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Boia R, Dias PA, Galindo-romero C, Ferreira H, Aires ID, Vidal-sanz M, Agudo-barriuso M, Bernardes R, Santos PF, de Sousa HC, Ambrósio AF, Braga ME, Santiago AR. Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ou K, Copland DA, Theodoropoulou S, Mertsch S, Li Y, Liu J, Schrader S, Liu L, Dick AD. Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment. J Cell Mol Med 2020;24:3958-70. [PMID: 32141716 DOI: 10.1111/jcmm.15016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Businaro R, Scaccia E, Bordin A, Pagano F, Corsi M, Siciliano C, Capoano R, Procaccini E, Salvati B, Petrozza V, Totta P, Vietri MT, Frati G, De Falco E. Platelet Lysate-Derived Neuropeptide y Influences Migration and Angiogenesis of Human Adipose Tissue-Derived Stromal Cells. Sci Rep. 2018;8:14365. [PMID: 30254326 DOI: 10.1038/s41598-018-32623-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Madeira MH, Boia R, Elvas F, Martins T, Cunha RA, Ambrósio AF, Santiago AR. Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury. Transl Res 2016;169:112-28. [PMID: 26685039 DOI: 10.1016/j.trsl.2015.11.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
5 Dulull NK, Thrimawithana TR, Kwa FAA. Mimicking the ocular environment for the study of inflammatory posterior eye disorders. Drug Discov Today 2017;22:440-6. [PMID: 27871941 DOI: 10.1016/j.drudis.2016.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
6 Campos EJ, Martins J, Brudzewsky D, Woldbye DPD, Ambrósio AF. Neuropeptide Y system mRNA expression changes in the hippocampus of a type I diabetes rat model. Ann Anat 2020;227:151419. [PMID: 31563570 DOI: 10.1016/j.aanat.2019.151419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Zhang Y, Liu CY, Chen WC, Shi YC, Wang CM, Lin S, He HF. Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review. Cell Biosci 2021;11:151. [PMID: 34344469 DOI: 10.1186/s13578-021-00657-7] [Reference Citation Analysis]
8 Cervia D, Catalani E, Casini G. Neuroprotective Peptides in Retinal Disease. J Clin Med 2019;8:E1146. [PMID: 31374938 DOI: 10.3390/jcm8081146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
9 Boia R, Ruzafa N, Aires ID, Pereiro X, Ambrósio AF, Vecino E, Santiago AR. Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead. Int J Mol Sci 2020;21:E2262. [PMID: 32218163 DOI: 10.3390/ijms21072262] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
10 Christiansen AT, Kiilgaard JF, Klemp K, Woldbye DPD, Hannibal J. Localization, distribution, and connectivity of neuropeptide Y in the human and porcine retinas-A comparative study. J Comp Neurol 2018;526:1877-95. [DOI: 10.1002/cne.24455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Yao Y, Hu Y, Yang J, Zhang C, He Y, Qi H, Zeng Y, Zhang A, Liu X, Zhu X. Inhibition of neuronal nitric oxide synthase protects against hippocampal neuronal injuries by increasing neuropeptide Y expression in temporal lobe epilepsy mice. Free Radic Biol Med 2022;188:45-61. [PMID: 35714846 DOI: 10.1016/j.freeradbiomed.2022.06.221] [Reference Citation Analysis]
12 Reboussin É, Buffault J, Brignole-Baudouin F, Réaux-Le Goazigo A, Riancho L, Olmiere C, Sahel JA, Mélik Parsadaniantz S, Baudouin C. Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model. J Neuroinflammation 2022;19:63. [PMID: 35236378 DOI: 10.1186/s12974-022-02418-w] [Reference Citation Analysis]
13 Peng S, Zhou YL, Song ZY, Lin S. Effects of Neuropeptide Y on Stem Cells and Their Potential Applications in Disease Therapy. Stem Cells Int. 2017;2017:6823917. [PMID: 29109742 DOI: 10.1155/2017/6823917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pöstyéni E, Ganczer A, Kovács-Valasek A, Gabriel R. Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice. Front Pharmacol 2021;12:808315. [PMID: 35095518 DOI: 10.3389/fphar.2021.808315] [Reference Citation Analysis]
15 Boia R, Elvas F, Madeira MH, Aires ID, Rodrigues-Neves AC, Tralhão P, Szabó EC, Baqi Y, Müller CE, Tomé ÂR, Cunha RA, Ambrósio AF, Santiago AR. Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death Dis 2017;8:e3065. [PMID: 28981089 DOI: 10.1038/cddis.2017.451] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
16 Campos EJ, Martins J, Brudzewsky D, Correia S, Santiago AR, Woldbye DP, Ambrósio AF. Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina. Clin Exp Ophthalmol 2018;46:783-95. [PMID: 29442423 DOI: 10.1111/ceo.13176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Christiansen AT, Sørensen NB, Haanes KA, Blixt FW, la Cour M, Warfvinge K, Klemp K, Woldbye DPD, Kiilgaard JF. Neuropeptide Y treatment induces retinal vasoconstriction and causes functional and histological retinal damage in a porcine ischaemia model. Acta Ophthalmol 2018;96:812-20. [PMID: 30218483 DOI: 10.1111/aos.13806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Kuehn S, Hurst J, Jashari A, Ahrens K, Tsai T, Wunderlich IM, Dick HB, Joachim SC, Schnichels S. The novel induction of retinal ganglion cell apoptosis in porcine organ culture by NMDA - an opportunity for the replacement of animals in experiments. Altern Lab Anim 2016;44:557-68. [PMID: 28094536 DOI: 10.1177/026119291604400608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
19 Opere CA, Heruye S, Njie-Mbye YF, Ohia SE, Sharif NA. Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection. J Ocul Pharmacol Ther 2018;34:107-18. [PMID: 29267132 DOI: 10.1089/jop.2017.0085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sheng W, Yu M, Wang X, Jin M, Pang X, Li C, Zhang S, Li P, Wang X, Zhang C, Zhang Y, Liu K. Localization of neuropeptide receptor NPY4R in rat retina. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102246] [Reference Citation Analysis]